President's Welcome
Mission / Vision
Leadership
SMA Alliance
Special Service Awards
Partners
Press Releases
Staff
Contact Us
Scientific Assembly 2009
2009 Call for Abstracts
Services
Resources
Checklists
Contact
Southern Medical Journal
SMJ CME Archives
Ask the Experts Series
CME/CE Calendar
MedEd On-Demand
Request a Brochure
Exhibitors
Physicians' Group Purchasing
SMA Tours
Insurance
Medical Communications Management
Resident and New Physicians Insurance Program
Financial Services
Retirement
Coding Nuggets
Patient's Page
Medical Webwatch
Online Resources
CMS Resources
Practice Management
Join SMA
Renew Membership
e-Membership
Member Benefits
SMAtips
Your Place in Today's Medicine Seminar
Articles and Tools
Life Curriculum - Resident Fatigue and Impairment
Group Purchasing
Handling The Job of Chief Resident
HomeLoginJoin/Renew SMA Services SMA Alliance
About SMA
Press Releases
 
For Immediate Release:
April 28,2008
Southern Medical Association Presents 12th Annual Conference on Hypertension in Savannah, Georgia

Contact:
Kristin Norris
Tel: 800.423.4992 ext. 134
Fax: 205.945.1548
E-mail: knorris@sma.org
Website:  www.sma.org/hyp 

Birmingham, Alabama – The Southern Medical Association (SMA), will present the 12th Annual Conference on Hypertension at the Westin Savannah Harbor Golf Resort & Spa in Savannah Georgia, July 18-20, 2008.

Jan N. Basile, MD, Director, Primary Care Service Line; Ralph H. Johnson Medical Center; Professor of Medicine, Medical University of South Carolina in Charleston, South Carolina is presiding as chairman of this conference. Other distinguished faculty include Pamela Arnold, MSN, APRN, BC-ADM, CDE, Clinical Director, Diabetes Initiative of South Carolina; Program Director, Diabetes Management Service; Medical University Hospital Authority; Medical University of South Carolina; Charleston, South Carolina; E. Benjamin Clyburn, MD, Associate Professor of Medicine, Program Director, and Vice Chair for Graduate Medical Education; Medical University of South Carolina; Charleston, South Carolina; Brent M. Egan, MD, Professor of Pharmacology and Medicine; Medical University of South Carolina; Charleston, South Carolina; Hertzel C. Gerstein, MD, MSc, FRCPC, Endocrinologist and Professor; McMaster University and Hamilton Health Sciences; Director of the Division of Endocrinology & Metabolism; Director of the Diabetes Care and Research Program; Hamilton, Ontario, Canada; John R. Guyton, MD, Associate Professor of Medicine; Director of Lipid Clinic, Duke University Medical Center; Durham, North Carolina; Daniel T. Lackland, DrPH, Professor of Epidemiology; Medical University of South Carolina; Charleston, South Carolina; Ronald K. Mayfield, MD, FACP, Director, Carolina’s Center for Diabetes and Endocrinology; Spartanburg Regional Healthcare Systems; Clinical Professor of Medicine; Medical University of South Carolina; Charleston, South Carolina; L. Michael Prisant, MD, FACC, FACP, Professor of Medicine; Director of Hypertension & Clinical Pharmacology; Medical College of Georgia; Augusta, GA; Leopoldo Raij, MD, Chief, Nephrology/Hypertension; Veterans Affairs Medical Center; Miami, FL; and Jeremy Soule, MD, Assistant Professor of Medicine; Division of Endocrinology; Medical University of South Carolina; Chief, Endocrine Section; Ralph H. Johnson VAMC; Charleston, South Carolina.

This three-day conference will focus on new strategies to identify patients with elevated global risk and emphasize the importance of reducing global risk along the entire CVD continuum. At the completion of this activity, participants should be better prepared to identify patients with elevated global cardiovascular risk and early-stage CVD, provide a rationale for expanding the classification of hypertension to include CVD risk factors, disease markers, and target organ damage, as well as outline a plan for reducing global risk and for preventing or slowing the progression of CVD by intervening at numerous steps in the cardiovascular continuum including hypertension, diabetes, and hyperlipidemia. Participants are invited to submit abstracts on clinical or research projects in the areas of hypertension, diabetes, and/or hyperlipidemia. Selected abstracts will be chosen for poster presentations during this conference. Deadline for receipt of abstracts is May 16, 2008. For complete abstract submission details or expanded activity information, visit www.sma.org/hyp.

This Medallion Level CME program is designed for physicians, physician assistants, nurse practitioners, nurses, and other healthcare professionals treating patients with hypertension, diabetes, and/or hyperlipidemia, alone or in combination. The Southern Medical Association designates this educational activity for 12.5 AMA PRA Category 1 CreditsTM, as well as nursing contact hours, lipid-focused CME, and other pending credits. Visit www.sma.org/hyp for updated credit approvals.

To register for this conference or for more information, please contact Kristin Norris at 1-800- 423.4992, ext. 134, knorris@sma.org, or visit us on the web at www.sma.org/hyp.

SMA values Advocacy, Leadership, Collegiality, and Innovation, and believes physicians must be advocates for their patients and provide the leadership necessary to promote better healthcare in their communities; that education and scholarly interactions must be conducted in a collegial, supportive environment; and that collaboration and innovation in healthcare delivery will best serve our patients as we work together to attain optimal health. Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and as an approved provider of continuing nursing education by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. For more information visit www.sma.org.


Copyright © 2010
Southern Medical Association
35 Lakeshore Drive
Birmingham, AL 35209
Tel: 800-423-4992
205-945-1840
Disclaimer | Privacy Policy
Website Advertising Policy